Cycloset Tablet
NDC Package 73515-123-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Cycloset (bromocriptine mesylate) tablets is a medication used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. This formulation utilizes a tablet delivery system. Marketed by Avvisto Therapeutics Llc, this product is identified by NDC 73515-123 and is authorized under FDA application NDA020866.

Identification & Billing

NDC Package Code
73515-123-30
Package Description
200 TABLET in 1 BOTTLE
Product Code
73515-123
11-Digit Billing Format
73515012330
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
200 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Cycloset
Non-Proprietary Name
Bromocriptine Mesylate
Substance Name
Bromocriptine Mesylate
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
BROMOCRIPTINE MESYLATE .8 mg/1
Pharmacologic Class
Usage Information
This medication is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Bromocriptine is an ergot medication that is believed to make your body's insulin function better, improving blood sugar control. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke.

Regulatory & Marketing

Labeler Name
Avvisto Therapeutics Llc
Product Type
Human Prescription Drug
FDA Application #
NDA020866
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
05-23-2024
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (73515-123). Click a package code to view its specific billing and regulatory data.

73515-123-21
21 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73515-123-30 identifies a specific commercial package of 200 tablet in 1 bottle of Cycloset, a human prescription drug labeled by Avvisto Therapeutics Llc. This tablet is formulated for oral use and contains bromocriptine mesylate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Avvisto Therapeutics Llc on May 23, 2024. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

This medication is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Bromocriptine is an ergot medication that is believed to make your body's insulin function better, improving blood sugar control. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke.

How is this Avvisto Therapeutics Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73515012330. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 200 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73515-123-30
11-Digit CMS (5-4-2)
73515-0123-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.